HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 282, Issue 23, 16829-16837, June 8, 2007

This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: 282/23/16829    most recent M701626200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Saikia, S. Articles by Scott, B. Search for Related Content PubMed PubMed Citation Articles by Saikia, S. Articles by Scott, B. Social Bookmarking                      What's this?

Defining Paxilline Biosynthesis in Penicillium paxilli

FUNCTIONAL CHARACTERIZATION OF TWO CYTOCHROME P450 MONOOXYGENASES^*

Sanjay Saikia, Emily J. Parker¹, Albert Koulman^¶, and Barry Scott²

From the Institute of Molecular Biosciences and the Institute of Fundamental Sciences, Massey University, Private Bag 11 222, Palmerston North, New Zealand and the ^¶AgResearch Grasslands Research Centre, Tennent Drive, Private Bag 11 008, Palmerston North, New Zealand

Indole diterpenes are a large, structurally and functionally diverse group of secondary metabolites produced by filamentous fungi. Biosynthetic schemes have been proposed for these metabolites but until recently none of the proposed steps had been validated by biochemical or genetic studies. Using Penicillium paxilli as a model experimental system to study indole diterpene biosynthesis we previously showed by deletion analysis that a cluster of seven genes is required for paxilline biosynthesis. Two of these pax genes, paxP and paxQ (encoding cytochrome P450 monooxygenases), are required in the later steps in this pathway. Here, we describe the function of paxP and paxQ gene products by feeding proposed paxilline intermediates to strains lacking the pax cluster but containing ectopically integrated copies of paxP or paxQ. Transformants containing paxP converted paspaline into 13-desoxypaxilline as the major product and -PC-M6 as the minor product. -PC-M6, but not -PC-M6, was also a substrate for PaxP and was converted to 13-desoxypaxilline. paxQ-containing transformants converted 13-desoxypaxilline into paxilline. These results confirm that paspaline, -PC-M6, and 13-desoxypaxilline are paxilline intermediates and that paspaline and -PC-M6 are substrates for PaxP, and 13-desoxypaxilline is a substrate for PaxQ. PaxP and PaxQ also utilized -paxitriol and -PC-M6 as substrates converting them to paxilline and -paxitriol, respectively. These findings have allowed us to delineate clearly the biosynthetic pathway for paxilline for the first time.

Received for publication, February 23, 2007 , and in revised form, April 3, 2007.

^* This work was supported by a grant from the Royal Society of New Zealand (Marsden Grant MAU010). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. 1 and 2.

¹ Present address: Dept. of Chemistry, Canterbury University, Private Bag 4800, Christchurch, New Zealand.

² To whom correspondence should be addressed: Tel.: +64 6 3505168; Fax: +64 6 3505688; E-mail: d.b.scott{at}massey.ac.nz.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?